{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T17:36:57Z","timestamp":1793036217554,"version":"4.5.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T00:00:00Z","timestamp":1734480000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T00:00:00Z","timestamp":1734480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Blood Cancer J."],"DOI":"10.1038\/s41408-024-01199-0","type":"journal-article","created":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T12:16:01Z","timestamp":1734524161000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Single-cell transcriptomic and spatial analysis reveal the immunosuppressive microenvironment in relapsed\/refractory angioimmunoblastic T-cell lymphoma"],"prefix":"10.1038","volume":"14","author":[{"given":"Mengyan","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9368-4987","authenticated-orcid":false,"given":"Lei","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongrong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yimin","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanyang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lishen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzhu","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueying","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayan","family":"Leng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyang","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingfei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runheng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanting","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diru","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingxiang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quanzhong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruize","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyu","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruohan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sali","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianyong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3488-1059","authenticated-orcid":false,"given":"Qianghu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9750-1810","authenticated-orcid":false,"given":"Kening","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,18]]},"reference":[{"key":"1199_CR1","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1002\/ajh.26499","volume":"97","author":"Y Wang","year":"2022","unstructured":"Wang Y, Zhang M, Song W, Cai Q, Zhang L, Sun X, et al. Chidamide plus prednisone, etoposide, and thalidomide for untreated angioimmunoblastic T-cell lymphoma in a Chinese population: a multicenter phase II trial. Am J Hematol. 2022;97:623\u20139. https:\/\/doi.org\/10.1002\/ajh.26499.","journal-title":"Am J Hematol"},{"key":"1199_CR2","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1158\/0008-5472.CAN-19-2787","volume":"80","author":"TB Nguyen","year":"2020","unstructured":"Nguyen TB, Sakata-Yanagimoto M, Fujisawa M, Nuhat ST, Miyoshi H, Nannya Y, et al. Dasatinib is an effective treatment for angioimmunoblastic T-cell lymphoma. Cancer Res. 2020;80:1875\u201384. https:\/\/doi.org\/10.1158\/0008-5472.CAN-19-2787.","journal-title":"Cancer Res"},{"key":"1199_CR3","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1200\/JCO.2011.37.3647","volume":"31","author":"M Federico","year":"2013","unstructured":"Federico M, Rudiger T, Bellei M, Nathwani BN, Luminari S, Coiffier B, et al. Clinicopathologic characteristics of angioimmunoblastic T-cell lymphoma: analysis of the international peripheral T-cell lymphoma project. J Clin Oncol. 2013;31:240\u20136. https:\/\/doi.org\/10.1200\/JCO.2011.37.3647.","journal-title":"J Clin Oncol"},{"key":"1199_CR4","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1097\/MOH.0b013e328186ffbf","volume":"14","author":"K Dunleavy","year":"2007","unstructured":"Dunleavy K, Wilson WH, Jaffe ES. Angioimmunoblastic T cell lymphoma: pathobiological insights and clinical implications. Curr Opin Hematol. 2007;14:348\u201353. https:\/\/doi.org\/10.1097\/MOH.0b013e328186ffbf.","journal-title":"Curr Opin Hematol"},{"key":"1199_CR5","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1182\/blood-2013-10-531509","volume":"123","author":"O Odejide","year":"2014","unstructured":"Odejide O, Weigert O, Lane AA, Toscano D, Lunning MA, Kopp N, et al. A targeted mutational landscape of angioimmunoblastic T-cell lymphoma. Blood. 2014;123:1293\u20136. https:\/\/doi.org\/10.1182\/blood-2013-10-531509.","journal-title":"Blood"},{"key":"1199_CR6","doi-asserted-by":"publisher","first-page":"2592","DOI":"10.1038\/s41375-020-0990-y","volume":"34","author":"S Chiba","year":"2020","unstructured":"Chiba S, Sakata-Yanagimoto M. Advances in understanding of angioimmunoblastic T-cell lymphoma. Leukemia. 2020;34:2592\u2013606. https:\/\/doi.org\/10.1038\/s41375-020-0990-y.","journal-title":"Leukemia"},{"key":"1199_CR7","doi-asserted-by":"publisher","first-page":"5480","DOI":"10.3390\/curroncol28060456","volume":"28","author":"MF Mohammed Saleh","year":"2021","unstructured":"Mohammed Saleh MF, Kotb A, Abdallah GEM, Muhsen IN, El Fakih R, Aljurf M. Recent advances in diagnosis and therapy of angioimmunoblastic T cell lymphoma. Curr Oncol. 2021;28:5480\u201398. https:\/\/doi.org\/10.3390\/curroncol28060456.","journal-title":"Curr Oncol"},{"key":"1199_CR8","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1200\/JOP.18.00511","volume":"15","author":"AJ Moskowitz","year":"2019","unstructured":"Moskowitz AJ. Practical treatment approach for angioimmunoblastic T-cell lymphoma. J Oncol Pr. 2019;15:137\u201343. https:\/\/doi.org\/10.1200\/JOP.18.00511.","journal-title":"J Oncol Pr"},{"key":"1199_CR9","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1200\/JCO.2012.44.7524","volume":"31","author":"V Mak","year":"2013","unstructured":"Mak V, Hamm J, Chhanabhai M, Shenkier T, Klasa R, Sehn LH, et al. Survival of patients with peripheral T-cell lymphoma after first relapse or progression: spectrum of disease and rare long-term survivors. J Clin Oncol. 2013;31:1970\u20136. https:\/\/doi.org\/10.1200\/JCO.2012.44.7524.","journal-title":"J Clin Oncol"},{"key":"1199_CR10","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1111\/bjh.12941","volume":"166","author":"MJ Ahearne","year":"2014","unstructured":"Ahearne MJ, Allchin RL, Fox CP, Wagner SD. Follicular helper T-cells: expanding roles in T-cell lymphoma and targets for treatment. Br J Haematol. 2014;166:326\u201335. https:\/\/doi.org\/10.1111\/bjh.12941.","journal-title":"Br J Haematol"},{"key":"1199_CR11","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1182\/blood-2016-09-692541","volume":"129","author":"MA Lunning","year":"2017","unstructured":"Lunning MA, Vose JM. Angioimmunoblastic T-cell lymphoma: the many-faced lymphoma. Blood. 2017;129:1095\u2013102. https:\/\/doi.org\/10.1182\/blood-2016-09-692541.","journal-title":"Blood"},{"key":"1199_CR12","doi-asserted-by":"publisher","first-page":"2915","DOI":"10.1182\/blood-2013-11-536359","volume":"123","author":"J Iqbal","year":"2014","unstructured":"Iqbal J, Wright G, Wang C, Rosenwald A, Gascoyne RD, Weisenburger DD, et al. Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma. Blood. 2014;123:2915\u201323. https:\/\/doi.org\/10.1182\/blood-2013-11-536359.","journal-title":"Blood"},{"key":"1199_CR13","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/s41375-021-01321-2","volume":"36","author":"JC Pritchett","year":"2022","unstructured":"Pritchett JC, Yang ZZ, Kim HJ, Villasboas JC, Tang X, Jalali S, et al. High-dimensional and single-cell transcriptome analysis of the tumor microenvironment in angioimmunoblastic T cell lymphoma (AITL). Leukemia. 2022;36:165\u201376. https:\/\/doi.org\/10.1038\/s41375-021-01321-2.","journal-title":"Leukemia"},{"key":"1199_CR14","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1182\/blood.2022015451","volume":"140","author":"M Fujisawa","year":"2022","unstructured":"Fujisawa M, Nguyen TB, Abe Y, Suehara Y, Fukumoto K, Suma S, et al. Clonal germinal center B cells function as a niche for T-cell lymphoma. Blood. 2022;140:1937\u201350. https:\/\/doi.org\/10.1182\/blood.2022015451.","journal-title":"Blood"},{"key":"1199_CR15","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/s41375-023-02093-7","volume":"38","author":"S Suma","year":"2024","unstructured":"Suma S, Suehara Y, Fujisawa M, Abe Y, Hattori K, Makishima K, et al. Tumor heterogeneity and immune-evasive T follicular cell lymphoma phenotypes at single-cell resolution. Leukemia. 2024;38:340\u201350. https:\/\/doi.org\/10.1038\/s41375-023-02093-7.","journal-title":"Leukemia"},{"key":"1199_CR16","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abk1692","volume":"7","author":"T Hoch","year":"2022","unstructured":"Hoch T, Schulz D, Eling N, Gomez JM, Levesque MP, Bodenmiller B. Multiplexed imaging mass cytometry of the chemokine milieus in melanoma characterizes features of the response to immunotherapy. Sci Immunol. 2022;7:eabk1692 https:\/\/doi.org\/10.1126\/sciimmunol.abk1692.","journal-title":"Sci Immunol"},{"key":"1199_CR17","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","volume":"127","author":"SH Swerdlow","year":"2016","unstructured":"Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127:2375\u201390. https:\/\/doi.org\/10.1182\/blood-2016-01-643569.","journal-title":"Blood"},{"key":"1199_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-14081-6","volume":"11","author":"AF Rendeiro","year":"2020","unstructured":"Rendeiro AF, Krausgruber T, Fortelny N, Zhao F, Penz T, Farlik M, et al. Chromatin mapping and single-cell immune profiling define the temporal dynamics of ibrutinib response in CLL. Nat Commun. 2020;11:577 https:\/\/doi.org\/10.1038\/s41467-019-14081-6.","journal-title":"Nat Commun"},{"key":"1199_CR19","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1182\/blood-2012-05-428938","volume":"121","author":"P Ramezani-Rad","year":"2013","unstructured":"Ramezani-Rad P, Geng H, Hurtz C, Chan LN, Chen Z, Jumaa H, et al. SOX4 enables oncogenic survival signals in acute lymphoblastic leukemia. Blood. 2013;121:148\u201355. https:\/\/doi.org\/10.1182\/blood-2012-05-428938.","journal-title":"Blood"},{"key":"1199_CR20","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/s43018-021-00220-w","volume":"2","author":"C Prieto","year":"2021","unstructured":"Prieto C, Nguyen DTT, Liu Z, Wheat J, Perez A, Gourkanti S, et al. Transcriptional control of CBX5 by the RNA binding proteins RBMX and RBMXL1 maintains chromatin state in myeloid leukemia. Nat Cancer. 2021;2:741\u201357. https:\/\/doi.org\/10.1038\/s43018-021-00220-w.","journal-title":"Nat Cancer"},{"key":"1199_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-022-03552-y","volume":"20","author":"Y Zheng","year":"2022","unstructured":"Zheng Y, Zhou Z, Wei R, Xiao C, Zhang H, Fan T, et al. The RNA-binding protein PCBP1 represses lung adenocarcinoma progression by stabilizing DKK1 mRNA and subsequently downregulating beta-catenin. J Transl Med. 2022;20:343 https:\/\/doi.org\/10.1186\/s12967-022-03552-y.","journal-title":"J Transl Med"},{"key":"1199_CR22","doi-asserted-by":"publisher","first-page":"647","DOI":"10.4161\/cbt.20082","volume":"13","author":"A Gastonguay","year":"2012","unstructured":"Gastonguay A, Berg T, Hauser AD, Schuld N, Lorimer E, Williams CL. The role of Rac1 in the regulation of NF-kappaB activity, cell proliferation, and cell migration in non-small cell lung carcinoma. Cancer Biol Ther. 2012;13:647\u201356. https:\/\/doi.org\/10.4161\/cbt.20082.","journal-title":"Cancer Biol Ther"},{"key":"1199_CR23","doi-asserted-by":"publisher","first-page":"3199","DOI":"10.1038\/onc.2014.242","volume":"34","author":"A Archibald","year":"2015","unstructured":"Archibald A, Mihai C, Macara IG, McCaffrey L. Oncogenic suppression of apoptosis uncovers a Rac1\/JNK proliferation pathway activated by loss of Par3. Oncogene. 2015;34:3199\u2013206. https:\/\/doi.org\/10.1038\/onc.2014.242.","journal-title":"Oncogene"},{"key":"1199_CR24","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1007\/s00018-008-8552-x","volume":"66","author":"EE Bosco","year":"2009","unstructured":"Bosco EE, Mulloy JC, Zheng Y. Rac1 GTPase: a \u201cRac\u201d of all trades. Cell Mol Life Sci. 2009;66:370\u20134. https:\/\/doi.org\/10.1007\/s00018-008-8552-x.","journal-title":"Cell Mol Life Sci"},{"key":"1199_CR25","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/s41577-021-00574-3","volume":"22","author":"M Philip","year":"2022","unstructured":"Philip M, Schietinger A. CD8(+) T cell differentiation and dysfunction in cancer. Nat Rev Immunol. 2022;22:209\u201323. https:\/\/doi.org\/10.1038\/s41577-021-00574-3.","journal-title":"Nat Rev Immunol"},{"key":"1199_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17046-2","volume":"11","author":"NG Nunez","year":"2020","unstructured":"Nunez NG, Tosello Boari J, Ramos RN, Richer W, Cagnard N, Anderfuhren CD, et al. Tumor invasion in draining lymph nodes is associated with Treg accumulation in breast cancer patients. Nat Commun. 2020;11:3272 https:\/\/doi.org\/10.1038\/s41467-020-17046-2.","journal-title":"Nat Commun"},{"key":"1199_CR27","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1002\/eji.201343718","volume":"44","author":"SE Church","year":"2014","unstructured":"Church SE, Jensen SM, Antony PA, Restifo NP, Fox BA. Tumor-specific CD4+ T cells maintain effector and memory tumor-specific CD8+ T cells. Eur J Immunol. 2014;44:69\u201379. https:\/\/doi.org\/10.1002\/eji.201343718.","journal-title":"Eur J Immunol"},{"key":"1199_CR28","doi-asserted-by":"publisher","first-page":"4107","DOI":"10.1182\/bloodadvances.2021006069","volume":"6","author":"CM Bourne","year":"2022","unstructured":"Bourne CM, Mun SS, Dao T, Aretz ZEH, Molvi Z, Gejman RS, et al. Unmasking the suppressed immunopeptidome of EZH2-mutated diffuse large B-cell lymphomas through combination drug treatment. Blood Adv. 2022;6:4107\u201321. https:\/\/doi.org\/10.1182\/bloodadvances.2021006069.","journal-title":"Blood Adv"},{"key":"1199_CR29","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1016\/j.celrep.2019.10.087","volume":"29","author":"A Ly","year":"2019","unstructured":"Ly A, Liao Y, Pietrzak H, Ioannidis LJ, Sidwell T, Gloury R, et al. Transcription factor T-bet in B cells modulates germinal center polarization and antibody affinity maturation in response to malaria. Cell Rep. 2019;29:2257\u201369 e6. https:\/\/doi.org\/10.1016\/j.celrep.2019.10.087.","journal-title":"Cell Rep"},{"key":"1199_CR30","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.semcancer.2013.11.004","volume":"24","author":"P Gaulard","year":"2014","unstructured":"Gaulard P, de Leval L. The microenvironment in T-cell lymphomas: emerging themes. Semin Cancer Biol. 2014;24:49\u201360. https:\/\/doi.org\/10.1016\/j.semcancer.2013.11.004.","journal-title":"Semin Cancer Biol"},{"key":"1199_CR31","doi-asserted-by":"publisher","first-page":"35247","DOI":"10.1074\/jbc.M505308200","volume":"280","author":"SJ Tzeng","year":"2005","unstructured":"Tzeng SJ, Bolland S, Inabe K, Kurosaki T, Pierce SK. The B cell inhibitory Fc receptor triggers apoptosis by a novel c-Abl family kinase-dependent pathway. J Biol Chem. 2005;280:35247\u201354. https:\/\/doi.org\/10.1074\/jbc.M505308200.","journal-title":"J Biol Chem"},{"key":"1199_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2017.61","volume":"7","author":"J Xiong","year":"2017","unstructured":"Xiong J, Wang L, Fei XC, Jiang XF, Zheng Z, Zhao Y, et al. MYC is a positive regulator of choline metabolism and impedes mitophagy-dependent necroptosis in diffuse large B-cell lymphoma. Blood Cancer J. 2017;7:e0 https:\/\/doi.org\/10.1038\/bcj.2017.61.","journal-title":"Blood Cancer J"},{"key":"1199_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-017-0033-8","volume":"7","author":"SK Leivonen","year":"2017","unstructured":"Leivonen SK, Icay K, Jantti K, Siren I, Liu C, Alkodsi A, et al. MicroRNAs regulate key cell survival pathways and mediate chemosensitivity during progression of diffuse large B-cell lymphoma. Blood Cancer J. 2017;7:654. https:\/\/doi.org\/10.1038\/s41408-017-0033-8.","journal-title":"Blood Cancer J"},{"key":"1199_CR34","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1038\/s41556-020-0532-x","volume":"22","author":"T Roider","year":"2020","unstructured":"Roider T, Seufert J, Uvarovskii A, Frauhammer F, Bordas M, Abedpour N, et al. Dissecting intratumour heterogeneity of nodal B-cell lymphomas at the transcriptional, genetic and drug-response levels. Nat Cell Biol. 2020;22:896\u2013906. https:\/\/doi.org\/10.1038\/s41556-020-0532-x.","journal-title":"Nat Cell Biol"},{"key":"1199_CR35","doi-asserted-by":"publisher","first-page":"3886","DOI":"10.1016\/j.molcel.2021.09.009","volume":"81","author":"CV Dang","year":"2021","unstructured":"Dang CV. Sex, life, and death in MYC-driven lymphomagenesis. Mol Cell. 2021;81:3886\u20137. https:\/\/doi.org\/10.1016\/j.molcel.2021.09.009.","journal-title":"Mol Cell"},{"key":"1199_CR36","doi-asserted-by":"publisher","unstructured":"Sun C, Cheng X, Wang C, Wang X, Xia B, Zhang Y. Gene expression profiles analysis identifies a novel two-gene signature to predict overall survival in diffuse large B-cell lymphoma. Biosci Rep. 2019;39. https:\/\/doi.org\/10.1042\/BSR20181293.","DOI":"10.1042\/BSR20181293"},{"key":"1199_CR37","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s13045-021-01103-4","volume":"14","author":"T Fu","year":"2021","unstructured":"Fu T, Dai LJ, Wu SY, Xiao Y, Ma D, Jiang YZ, et al. Spatial architecture of the immune microenvironment orchestrates tumor immunity and therapeutic response. J Hematol Oncol. 2021;14:98. https:\/\/doi.org\/10.1186\/s13045-021-01103-4.","journal-title":"J Hematol Oncol"},{"key":"1199_CR38","doi-asserted-by":"publisher","first-page":"4463","DOI":"10.1182\/blood-2007-08-105759","volume":"111","author":"N Mourad","year":"2008","unstructured":"Mourad N, Mounier N, Briere J, Raffoux E, Delmer A, Feller A, et al. Clinical, biologic, and pathologic features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the Groupe d\u2019Etude des Lymphomes de l\u2019Adulte (GELA) trials. Blood. 2008;111:4463\u201370. https:\/\/doi.org\/10.1182\/blood-2007-08-105759.","journal-title":"Blood"},{"key":"1199_CR39","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1093\/annonc\/mdz006","volume":"30","author":"CH Takimoto","year":"2019","unstructured":"Takimoto CH, Chao MP, Gibbs C, McCamish MA, Liu J, Chen JY, et al. The Macrophage \u2018Do not eat me\u2019 signal, CD47, is a clinically validated cancer immunotherapy target. Ann Oncol. 2019;30:486\u20139. https:\/\/doi.org\/10.1093\/annonc\/mdz006.","journal-title":"Ann Oncol"},{"key":"1199_CR40","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.cell.2010.07.044","volume":"142","author":"MP Chao","year":"2010","unstructured":"Chao MP, Alizadeh AA, Tang C, Myklebust JH, Varghese B, Gill S, et al. Anti-CD47 antibody synergizes with rituximab to promote phagocytosis and eradicate non-Hodgkin lymphoma. Cell. 2010;142:699\u2013713. https:\/\/doi.org\/10.1016\/j.cell.2010.07.044.","journal-title":"Cell"},{"key":"1199_CR41","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s13045-020-01006-w","volume":"13","author":"K Izykowska","year":"2020","unstructured":"Izykowska K, Rassek K, Korsak D, Przybylski GK. Novel targeted therapies of T cell lymphomas. J Hematol Oncol. 2020;13:176. https:\/\/doi.org\/10.1186\/s13045-020-01006-w.","journal-title":"J Hematol Oncol"},{"key":"1199_CR42","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1016\/j.immuni.2022.10.004","volume":"55","author":"Z Czimmerer","year":"2022","unstructured":"Czimmerer Z, Halasz L, Daniel B, Varga Z, Bene K, Domokos A, et al. The epigenetic state of IL-4-polarized macrophages enables inflammatory cistromic expansion and extended synergistic response to TLR ligands. Immunity. 2022;55:2006\u201326.e6. https:\/\/doi.org\/10.1016\/j.immuni.2022.10.004.","journal-title":"Immunity"},{"key":"1199_CR43","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/j.cell.2021.01.022","volume":"184","author":"ND Mathewson","year":"2021","unstructured":"Mathewson ND, Ashenberg O, Tirosh I, Gritsch S, Perez EM, Marx S, et al. Inhibitory CD161 receptor identified in glioma-infiltrating T cells by single-cell analysis. Cell. 2021;184:1281\u201398.e26. https:\/\/doi.org\/10.1016\/j.cell.2021.01.022.","journal-title":"Cell"},{"key":"1199_CR44","doi-asserted-by":"publisher","first-page":"6246","DOI":"10.1038\/onc.2016.160","volume":"35","author":"A Ghoochani","year":"2016","unstructured":"Ghoochani A, Schwarz MA, Yakubov E, Engelhorn T, Doerfler A, Buchfelder M, et al. MIF-CD74 signaling impedes microglial M1 polarization and facilitates brain tumorigenesis. Oncogene. 2016;35:6246\u201361. https:\/\/doi.org\/10.1038\/onc.2016.160.","journal-title":"Oncogene"},{"key":"1199_CR45","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.3389\/fimmu.2018.01132","volume":"9","author":"CR Figueiredo","year":"2018","unstructured":"Figueiredo CR, Azevedo RA, Mousdell S, Resende-Lara PT, Ireland L, Santos A, et al. Blockade of MIF-CD74 signalling on macrophages and dendritic cells restores the antitumour immune response against metastatic melanoma. Front Immunol. 2018;9:1132. https:\/\/doi.org\/10.3389\/fimmu.2018.01132.","journal-title":"Front Immunol"},{"key":"1199_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2022.215972","volume":"551","author":"Y Du","year":"2022","unstructured":"Du Y, Cai Y, Lv Y, Zhang L, Yang H, Liu Q, et al. Single-cell RNA sequencing unveils the communications between malignant T and myeloid cells contributing to tumor growth and immunosuppression in cutaneous T-cell lymphoma. Cancer Lett. 2022;551:215972. https:\/\/doi.org\/10.1016\/j.canlet.2022.215972.","journal-title":"Cancer Lett"},{"key":"1199_CR47","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/j.immuni.2014.12.005","volume":"41","author":"PT Sage","year":"2014","unstructured":"Sage PT, Paterson AM, Lovitch SB, Sharpe AH. The coinhibitory receptor CTLA-4 controls B cell responses by modulating T follicular helper, T follicular regulatory, and T regulatory cells. Immunity. 2014;41:1026\u201339. https:\/\/doi.org\/10.1016\/j.immuni.2014.12.005.","journal-title":"Immunity"},{"key":"1199_CR48","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1126\/science.aaa6204","volume":"348","author":"JA Joyce","year":"2015","unstructured":"Joyce JA, Fearon DT. T cell exclusion, immune privilege, and the tumor microenvironment. Science. 2015;348:74\u201380. https:\/\/doi.org\/10.1126\/science.aaa6204.","journal-title":"Science"},{"key":"1199_CR49","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/nrc3239","volume":"12","author":"DM Pardoll","year":"2012","unstructured":"Pardoll DM. The blockade of immune checkpoints in cancer immunotherapy. Nat Rev Cancer. 2012;12:252\u201364. https:\/\/doi.org\/10.1038\/nrc3239.","journal-title":"Nat Rev Cancer"},{"key":"1199_CR50","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1038\/nm.3931","volume":"21","author":"X Liu","year":"2015","unstructured":"Liu X, Pu Y, Cron K, Deng L, Kline J, Frazier WA, et al. CD47 blockade triggers T cell-mediated destruction of immunogenic tumors. Nat Med. 2015;21:1209\u201315. https:\/\/doi.org\/10.1038\/nm.3931.","journal-title":"Nat Med"},{"key":"1199_CR51","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.omtn.2020.06.018","volume":"21","author":"Q Guo","year":"2020","unstructured":"Guo Q, Wang T, Yang Y, Gao L, Zhao Q, Zhang W, et al. Transcriptional factor Yin Yang 1 promotes the stemness of breast cancer cells by suppressing miR-873-5p transcriptional activity. Mol Ther Nucleic Acids. 2020;21:527\u201341. https:\/\/doi.org\/10.1016\/j.omtn.2020.06.018.","journal-title":"Mol Ther Nucleic Acids"},{"key":"1199_CR52","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1186\/s13046-023-02863-2","volume":"42","author":"S Deng","year":"2023","unstructured":"Deng S, Cheng D, Wang J, Gu J, Xue Y, Jiang Z, et al. MYL9 expressed in cancer-associated fibroblasts regulate the immune microenvironment of colorectal cancer and promotes tumor progression in an autocrine manner. J Exp Clin Cancer Res. 2023;42:294. https:\/\/doi.org\/10.1186\/s13046-023-02863-2.","journal-title":"J Exp Clin Cancer Res"},{"key":"1199_CR53","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1093\/annonc\/mdv615","volume":"27","author":"J Chen","year":"2016","unstructured":"Chen J, Jiang CC, Jin L, Zhang XD. Regulation of PD-L1: a novel role of pro-survival signalling in cancer. Ann Oncol. 2016;27:409\u201316. https:\/\/doi.org\/10.1093\/annonc\/mdv615.","journal-title":"Ann Oncol"},{"key":"1199_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-13-209","volume":"13","author":"JG Fernandez","year":"2014","unstructured":"Fernandez JG, Rodriguez DA, Valenzuela M, Calderon C, Urzua U, Munroe D, et al. Survivin expression promotes VEGF-induced tumor angiogenesis via PI3K\/Akt enhanced beta-catenin\/Tcf-Lef dependent transcription. Mol Cancer. 2014;13:209 https:\/\/doi.org\/10.1186\/1476-4598-13-209.","journal-title":"Mol Cancer"},{"key":"1199_CR55","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1038\/s41564-019-0541-3","volume":"4","author":"X Long","year":"2019","unstructured":"Long X, Wong CC, Tong L, Chu ESH, Ho Szeto C, Go MYY, et al. Peptostreptococcus anaerobius promotes colorectal carcinogenesis and modulates tumour immunity. Nat Microbiol. 2019;4:2319\u201330. https:\/\/doi.org\/10.1038\/s41564-019-0541-3.","journal-title":"Nat Microbiol"},{"key":"1199_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3598","volume":"4","author":"C Ramkumar","year":"2013","unstructured":"Ramkumar C, Cui H, Kong Y, Jones SN, Gerstein RM, Zhang H. Smurf2 suppresses B-cell proliferation and lymphomagenesis by mediating ubiquitination and degradation of YY1. Nat Commun. 2013;4:2598. https:\/\/doi.org\/10.1038\/ncomms3598.","journal-title":"Nat Commun"},{"key":"1199_CR57","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1158\/0008-5472.CAN-18-2238","volume":"79","author":"J Han","year":"2019","unstructured":"Han J, Meng J, Chen S, Wang X, Yin S, Zhang Q, et al. YY1 complex promotes quaking expression via super-enhancer binding during EMT of hepatocellular carcinoma. Cancer Res. 2019;79:1451\u201364. https:\/\/doi.org\/10.1158\/0008-5472.CAN-18-2238.","journal-title":"Cancer Res"},{"key":"1199_CR58","doi-asserted-by":"publisher","first-page":"3403","DOI":"10.1093\/nar\/gkr1290","volume":"40","author":"P Vella","year":"2012","unstructured":"Vella P, Barozzi I, Cuomo A, Bonaldi T, Pasini D. Yin Yang 1 extends the Myc-related transcription factors network in embryonic stem cells. Nucleic Acids Res. 2012;40:3403\u201318. https:\/\/doi.org\/10.1093\/nar\/gkr1290.","journal-title":"Nucleic Acids Res"},{"key":"1199_CR59","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1126\/science.aac9935","volume":"352","author":"SC Casey","year":"2016","unstructured":"Casey SC, Tong L, Li Y, Do R, Walz S, Fitzgerald KN, et al. MYC regulates the antitumor immune response through CD47 and PD-L1. Science. 2016;352:227\u201331. https:\/\/doi.org\/10.1126\/science.aac9935.","journal-title":"Science"},{"key":"1199_CR60","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1182\/blood.2020010497","volume":"138","author":"D Chihara","year":"2021","unstructured":"Chihara D, Dores GM, Flowers CR, Morton LM. The bidirectional increased risk of B-cell lymphoma and T-cell lymphoma. Blood. 2021;138:785\u20139. https:\/\/doi.org\/10.1182\/blood.2020010497.","journal-title":"Blood"},{"key":"1199_CR61","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1746-1596-7-7","volume":"7","author":"QX Yang","year":"2012","unstructured":"Yang QX, Pei XJ, Tian XY, Li Y, Li Z. Secondary cutaneous Epstein-Barr virus-associated diffuse large B-cell lymphoma in a patient with angioimmunoblastic T-cell lymphoma: a case report and review of literature. Diagn Pathol. 2012;7:7. https:\/\/doi.org\/10.1186\/1746-1596-7-7.","journal-title":"Diagn Pathol"},{"key":"1199_CR62","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s10059-013-0154-2","volume":"36","author":"I Hwang","year":"2013","unstructured":"Hwang I. Cell-cell communication via extracellular membrane vesicles and its role in the immune response. Mol Cells. 2013;36:105\u201311. https:\/\/doi.org\/10.1007\/s10059-013-0154-2.","journal-title":"Mol Cells"},{"key":"1199_CR63","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11738-0","volume":"10","author":"Z Xiao","year":"2019","unstructured":"Xiao Z, Dai Z, Locasale JW. Metabolic landscape of the tumor microenvironment at single cell resolution. Nat Commun. 2019;10:3763. https:\/\/doi.org\/10.1038\/s41467-019-11738-0.","journal-title":"Nat Commun"},{"key":"1199_CR64","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1111\/febs.15102","volume":"287","author":"Y Du","year":"2020","unstructured":"Du Y, Li K, Wang X, Kaushik AC, Junaid M, Wei D. Identification of chlorprothixene as a potential drug that induces apoptosis and autophagic cell death in acute myeloid leukemia cells. FEBS J. 2020;287:1645\u201365. https:\/\/doi.org\/10.1111\/febs.15102.","journal-title":"FEBS J"},{"key":"1199_CR65","doi-asserted-by":"publisher","unstructured":"Windhager J, Zanotelli VRT, Schulz D, Meyer L, Daniel M, Bodenmiller B, et al. An end-to-end workflow for multiplexed image processing and analysis. Nat Protoc. 2023;18:3565\u2013613. https:\/\/doi.org\/10.1038\/s41596-023-00881-0.","DOI":"10.1038\/s41596-023-00881-0"},{"key":"1199_CR66","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1038\/nmeth.4391","volume":"14","author":"D Schapiro","year":"2017","unstructured":"Schapiro D, Jackson HW, Raghuraman S, Fischer JR, Zanotelli VRT, Schulz D, et al. histoCAT: analysis of cell phenotypes and interactions in multiplex image cytometry data. Nat Methods. 2017;14:873\u20136. https:\/\/doi.org\/10.1038\/nmeth.4391.","journal-title":"Nat Methods"}],"container-title":["Blood Cancer Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41408-024-01199-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41408-024-01199-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41408-024-01199-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T13:02:26Z","timestamp":1734526946000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41408-024-01199-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,18]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1199"],"URL":"https:\/\/doi.org\/10.1038\/s41408-024-01199-0","relation":{},"ISSN":["2044-5385"],"issn-type":[{"value":"2044-5385","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,18]]},"assertion":[{"value":"5 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was reviewed and approved by the Ethical Committee of the Nanjing Medical University (Nanjing, Jiangsu, China). The study was performed after receiving written informed consent from patients, by the principles outlined in the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"218"}}